ICD-10 Coding for Thrombocytosis(D47.3, D47.3B, D47.3E)
Comprehensive guide on thrombocytosis ICD-10 coding, including essential and secondary thrombocythemia, with documentation requirements and clinical validation.
Complete code families applicable to Thrombocytosis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D47.3 | Essential (primary) thrombocythemia | Use when essential thrombocythemia is confirmed through clinical and laboratory findings. |
|
| D75.81 | Secondary thrombocytosis | Use when thrombocytosis is secondary to another documented condition. |
|
| D75.839 | Unspecified thrombocytosis | Use when thrombocytosis is present but the cause is not specified or documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutThrombocytosis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Thrombocytosis.
Failing to document the underlying cause of secondary thrombocytosis.
Impact
Clinical: May lead to inappropriate treatment., Regulatory: Non-compliance with coding standards., Financial: Potential for reduced reimbursement.
Mitigation
Always document the underlying condition causing thrombocytosis., Use templates to ensure comprehensive documentation.
Using D75.839 when the cause is known but not documented.
Impact
Reimbursement: May lead to lower reimbursement due to unspecified coding., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases the accuracy of health records.
Mitigation
Query the provider to specify the cause of thrombocytosis.
Unspecified Coding
Impact
Using unspecified codes when specific causes are known.
Mitigation
Ensure thorough documentation of all relevant clinical findings and underlying conditions.